Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 5/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8589220 | 0.75 | SIGMAR1 (0.53) | MEN1KMT2ASIGMAR1OPRM1 | |
| Hydrochloric Acid SCHEMBL8590503 | 0.74 | SIGMAR1 (0.52) | MEN1KMT2ASIGMAR1OPRM1 | |
| SCHEMBL9032349 | 0.74 | KCNH2 (0.47) | SLC6A4SLC6A3SLC6A2MEN1ALDH1A1 | |
| SCHEMBL574717 | 0.73 | SLC6A4 (0.60) | SLC6A4SLC6A3SLC6A2MEN1ALDH1A1 | |
| SCHEMBL574718 | 0.72 | SLC6A3 (0.59) | SLC6A4SLC6A3SLC6A2MEN1ALDH1A1 | |
| SCHEMBL11789646 | 0.72 | SIGMAR1 (0.62) | SIGMAR1OPRM1 | |
| SCHEMBL8589283 | 0.72 | SIGMAR1 (0.49) | MEN1KMT2ASIGMAR1 | |
| Vanoxerine SCHEMBL246574 | 0.72 | SLC6A4 (1.00) | SLC6A4SLC6A3SLC6A2MEN1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8587935 | 0.71 | EBP (0.48) | MEN1KMT2ASIGMAR1 | |
| Vanoxerine SCHEMBL15541249 | 0.71 | SLC6A4 (1.00) | SLC6A4SLC6A3SLC6A2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2646032-A1 | THERAPEUTIC TREATMENT FOR METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR PREDIABETES | VeroScience LLC (US) | 2013-10-09 | — | — | EP | disclosed |
| EP-2579876-A2 | THERAPEUTIC TREATMENT FOR METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY, OR PREDIABETES | VeroScience LLC (US) | 2013-04-17 | — | — | EP | disclosed |
| WO-2012071295-A1 | THERAPEUTIC TREATMENT FOR METABOLIC SYNDROME, TYPE 2 DIABETES, OBESTIY OR PREDIABETES | VEROSCIENCE, LLC (US) | 2012-05-31 | — | — | WO | disclosed |
| WO-2011156248-A2 | THERAPEUTIC TREATMENT FOR METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY, OR PREDIABETES | VEROSCIENCE, LLC (US) | 2011-12-15 | — | — | WO | disclosed |
| EP-2175853-A1 | METHODS OF TREATING METABOLIC SYNDROME USING DOPAMINE RECEPTOR AGONISTS | VeroScience LLC (US) | 2010-04-21 | — | — | EP | disclosed |
| EP-2162003-A1 | THERAPEUTIC TREATMENT FOR METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY, OR PREDIABETES | VeroScience LLC (US) | 2010-03-17 | — | — | EP | disclosed |
| WO-2008150480-A1 | THERAPEUTIC TREATMENT FOR METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY, OR PREDIABETES | VEROSCIENCE, LLC (US) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008121258-A1 | METHODS OF TREATING METABOLIC SYNDROME USING DOPAMINE RECEPTOR AGONISTS | VEROSCIENCE, LLC (US) | 2008-10-09 | — | — | WO | disclosed |